Inhalac 230
Dry powder inhalants are often used in the pulmonary route of administration. Its advantages include excellent ease of use, small size for portability, and no precise fit (relative to aerosol) between device excitation and patient breathing. In addition, because it does not contain Freon, it is more environmentally friendly. In use and storage, solid dosage forms have better physicochemical stability. Dry powder inhalants generally consist of a device, drugs and auxiliaries. Additives are added to ensure a smooth production process. Therefore, the particle properties of powders related to the process are important factors that need to be paid attention to in the design of prescriptions.
InhaLac® 230 (median 100 micron) is a product with a narrow particle size distribution obtained by sieving (peak width to height ratio of about 1.0). The fine powder content is 3-4%.
previous item: Inhalac 120
next item: Inhalac 251





关闭返回